[Drug therapy in angina pectoris]

Area of Science:

• Cardiology
• Pharmacology

Context:

• Current antianginal drugs primarily reduce myocardial oxygen demand or induce coronary vasodilation.
• Treatment selection is individualized based on clinical presentation, comorbidities, and patient-specific factors.

Purpose:

• To discuss the comparative efficacy and indications of various antianginal drug classes.
• To highlight the importance of secondary prophylactic measures in managing coronary artery disease.

Summary:

• Antianginal therapies include beta blockers, nitrates, and calcium antagonists, with choices tailored to individual patient needs.
• Effective management involves both symptomatic relief and secondary prevention strategies like aspirin and lipid-lowering therapies.
• The paper reviews the comparative effectiveness and appropriate use of different antianginal medications.

Impact:

• Provides guidance for clinicians in selecting optimal antianginal therapy.
• Emphasizes a comprehensive approach to coronary artery disease management, including secondary prevention.
• Aims to improve patient outcomes by optimizing treatment strategies for angina pectoris.